Comparison of docetaxel pharmacokinetics between castration-resistant and hormone-sensitive metastatic prostate cancer patients

被引:0
|
作者
Marit A. C. Vermunt
Merel van Nuland
Lisa T. van der Heijden
Hilde Rosing
Jos. H. Beijnen
Andries M. Bergman
机构
[1] The Netherlands Cancer Institute,Department of Pharmacy and Pharmacology
[2] The Netherlands Cancer Institute,Department of Medical Oncology
[3] Utrecht University,Department of Pharmaceutical Sciences
[4] Modra Pharmaceuticals B.V.,Department of Oncogenomics
[5] The Netherlands Cancer Institute,undefined
来源
关键词
Docetaxel; Pharmacokinetics; Metastatic castration-resistant prostate cancer; Metastatic hormone-sensitive prostate cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:785 / 793
页数:8
相关论文
共 50 条
  • [41] Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer
    Heck, Matthias M.
    Thalgott, Mark
    Retz, Margitta
    Wolf, Petra
    Maurer, Tobias
    Nawroth, Roman
    Hatzichristodoulou, Georgios
    Gschwend, Jurgen E.
    Kuebler, Huebert
    BJU INTERNATIONAL, 2012, 110 (11B) : E635 - E640
  • [42] Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
    Conteduca, Vincenza
    Jayaram, Anuradha
    Romero-Laorden, Nuria
    Wetterskog, Daniel
    Salvi, Samanta
    Gurioli, Giorgia
    Scarpi, Emanuela
    Castro, Elena
    Marin-Aguilera, Mercedes
    Lolli, Cristian
    Schepisi, Giuseppe
    Maugeri, Antonio
    Wingate, Anna
    Farolfi, Alberto
    Casadio, Valentina
    Medina, Ana
    Puente, Javier
    Mendez Vidal, Ma Jose
    Morales-Barrera, Rafael
    Villa-Guzman, Jose C.
    Hernando, Susana
    Rodriguez-Vida, Alejo
    Gonzalez-del-Alba, Aranzazu
    Mellado, Begona
    Gonzalez-Billalabeitia, Enrique
    Olmos, David
    Attard, Gerhardt
    De Giorgi, Ugo
    EUROPEAN UROLOGY, 2019, 75 (03) : 368 - 373
  • [43] Docetaxel rechallenge chemotherapy in metastatic castration-resistant prostate cancer (mCRPC).
    Bracarda, S.
    Sisani, M.
    Rossi, M.
    Galli, L.
    Hamzaj, A.
    Scali, S.
    De Angelis, V.
    Falcone, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer
    Armstrong, A. J.
    George, D. J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (02) : 108 - 116
  • [45] Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer
    A J Armstrong
    D J George
    Prostate Cancer and Prostatic Diseases, 2010, 13 : 108 - 116
  • [46] Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel
    Ryan, Charles J.
    Dutta, Sandipan
    Kelly, William K.
    Middleberg, Rob
    Russell, Carly
    Morris, Michael J.
    Taplin, Mary-Ellen
    Halabi, Susan
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 222 - +
  • [47] Sequencing new agents after docetaxel in patients with metastatic castration-resistant prostate cancer
    Maines, Francesca
    Caffo, Orazio
    Veccia, Antonello
    Trentin, Chiara
    Tortora, Giampaolo
    Galligioni, Enzo
    Bria, Emilio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 498 - 506
  • [48] SEQUENCING NEW AGENTS AFTER DOCETAXEL IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Maines, Francesca
    Caffo, Orazio
    Veccia, Antonello
    Tortora, Giampaolo
    Galligioni, Enzo
    Bria, Emilio
    ANTICANCER RESEARCH, 2015, 35 (06) : 3716 - 3716
  • [49] Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer
    Madan, Ravi A.
    Karzai, Fatima H.
    Al Harthy, Munjid
    Petrylak, Daniel P.
    Kim, Joseph W.
    Arlen, Philip M.
    Rosner, Inger
    Theoret, Marc R.
    Cordes, Lisa
    Bilusic, Marijo
    Peer, Cody J.
    Dawson, Nancy A.
    Couvillon, Anna
    Hankin, Amy
    Williams, Moniquea
    Chun, Guin
    Owens, Helen
    Marte, Jennifer L.
    Lee, Min-Jung
    Tomita, Yusuke
    Yuno, Akira
    Trepel, Jane B.
    Lee, Sunmin
    Steinberg, Seth M.
    Gulley, James L.
    Figg, William D.
    Dahut, William L.
    BJU INTERNATIONAL, 2021, 127 (04) : 435 - 444
  • [50] Docetaxel in very elderly men with metastatic castration-resistant prostate cancer
    Wong, Hui-Li
    Lok, Sheau Wen
    Wong, Shirley
    Parente, Phillip
    Rosenthal, Mark
    PROSTATE INTERNATIONAL, 2015, 3 (02) : 42 - 46